chr2-216369927-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020814.3(MARCHF4):c.334C>T(p.Pro112Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,609,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020814.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MARCHF4 | NM_020814.3 | c.334C>T | p.Pro112Ser | missense_variant | 1/4 | ENST00000273067.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MARCHF4 | ENST00000273067.5 | c.334C>T | p.Pro112Ser | missense_variant | 1/4 | 1 | NM_020814.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000541 AC: 13AN: 240228Hom.: 0 AF XY: 0.0000459 AC XY: 6AN XY: 130824
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1457440Hom.: 0 Cov.: 32 AF XY: 0.00000690 AC XY: 5AN XY: 724534
GnomAD4 genome AF: 0.000210 AC: 32AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2024 | The c.334C>T (p.P112S) alteration is located in exon 1 (coding exon 1) of the MARCH4 gene. This alteration results from a C to T substitution at nucleotide position 334, causing the proline (P) at amino acid position 112 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at